Le Lézard
Classified in: Health, Science and technology
Subject: Product/Service

At a CAGR of 7%, Vascular Patches Market to Surpass US$ 7,665.5 Million Globally by End of 2027, Says Coherent Market Insights (CMI)


According to Coherent Market Insights, the global vascular patches market is estimated to be valued at US$ 4,778.33 million in 2020 and is expected to exhibit a CAGR of 7.0% during the forecast period (2020-2027).

Key Trends and Analysis of the Global Vascular Patches Market:

Key trends in the market include increasing geriatric population, rising cases of cardiovascular diseases, launches of novel products, and adoption of inorganic strategies by key players.

Market players are focusing on launching new products, which is expected to drive the market growth. For instance, in November 2018, CorMatrix Cardiovascular Inc., a medical device company engaged in developing biomaterial devices, received the U.S. Food and Drug Administration (U.S. FDA) approval to commercialize its CorMatrix extracellular matrix (ECM) for vascular repair. The product is intended to use for repair and reconstruction of peripheral vasculature and patch closure of vessels to regenerate viable autogenous tissue.

However, product recalls in the market is expected to hinder the market growth. For instance, in June 2015, Baxter International Inc., a developer and manufacturer of medical devices, pharmaceuticals and biotechnology products, voluntarily recalled four product codes of its VASCU-GUARD, a peripheral vascular patch. The product is recalled Baxter due to received customer complaints of difficulty in distinguishing the smooth from rough surface of the VASCU-GUARD patch.

Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/4371

Key Market Takeaways:

The global vascular patches market is expected to exhibit a CAGR of 7.0% during the forecast period, owing to rising cardiovascular diseases. For instance, according to an article published in the National Center for Biotechnology Information (NCBI), 2020, globally around 126 million people suffered from ischemic heart disease (1,655 per 100,000), which constituted to 1.72% of the total world population, in 2017.

Rising geriatric population in worldwide is expected to propel the market growth during the forecast period. For instance, according to an article published in the World Population Prospects: the 2019, by 2050, 1 in 6 people in the world will be over age 65 (16%), up from 1 in 11 in 2019 (9%).

Competitive Landscape:

Key players operating in the global vascular patches market include B. Braun Melsungen AG, C. R. Bard, Inc., LeMaitre Vascular, Inc., Getinge AB (Maquet), W. L. Gore & Associates, Inc., Edwards Lifesciences Corporation, Baxter International Inc., CryoLife, Inc., Medtronic, and Admedus, among others.

Request Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/4371

Market Segmentation:

Related Market Intelligence Reports:

Neurovascular Devices Market, by Device Type (Embolization Coils (Platinum Coils, Coated Platinum Coils, and Liquid Embolic Coils), Neurovascular Stents (Carotid Artery Stents and Flow Diversion Stents), Neurothrombectomy Devices (Clot Retrievers, Aspiration/ Suction Devices, and Vascular Snares), Embolic Protection Devices (Distal Filter Devices and Balloon Occlusion Devices), and Neurovascular Supporting Devices (Microcatheters and Microguidewires)), by Therapeutic Application (Cerebral Aneurysms, Ischemic Stroke, Cerebral Artery Stenosis, Arteriovenous Malformations (AVMs) and AV Fistulas, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

Read more: https://www.coherentmarketinsights.com/market-insight/neurovascular-devices-market-4224

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide.


These press releases may also interest you

at 05:35
Allegion plc , a leading global security products and solutions provider, today reported financial results for its first quarter (ended March 31, 2024). "Allegion's Q1 performance sets a solid foundation for the year," said John H. Stone, Allegion...

at 05:30
Breach Secure Now, the channel leader in providing cybersecurity and productivity training and solutions, is pleased to announce the appointment of Dan Cucchi as its new Vice President of Sales. In this role, Cucchi will oversee the company's sales...

at 05:25
PureTech Health plc ("PureTech" or the "Company") today announces its results for the year ended December 31, 2023, as well as its cash balance as of the first quarter ended March 31, 2024. The following information represents select highlights from...

at 05:20
A new report from the Bitrue throws down the gauntlet to Big Tech, highlighting how decentralized GPU (Graphics Processing Unit) rental markets could democratize access to computational power and disrupt the current AI resource landscape. The report...

at 05:19
Soft2Bet already operates the market-leading Betinia website in Denmark and is set to once again revolutionise the market with CampoBet, a mobile-first sportsbook, and casino that will provide an unparalleled gaming experience to Danish players....

at 05:11
Hyundai Bioscience announced on April 25th that its clinical development plan of oral "Niclosamide Metabolic Anticancer Drug" targeting cancer patients with intractable cancer caused by p53 gene mutations. Mutations in the p53 gene occur in almost...



News published on and distributed by: